GAS5 and early-onset autosomal dominant Alzheimer disease: To evaluate the levels of GAS5 in the brain, RNA from human medial temporal lobe from Alzheimer’s disease (AD) patients or age matched normal (no cancers, 70–85 years, male and female, n = 9; from Byrd Alzheimer’s Institute) were obtained and analyzed using real-time qPCR.